IP Library Granted Patent US 10,031,145
Granted Patent B2
US 10,031,145 · App. 14/001,766 · Granted Jul 24, 2018

Method for quantifying cholesterol in high-density lipoprotein 2, and reagent kit for the method

Inventors: Maiko Higuchi (Gosen, JP); Yasuki Itoh (Gosen, JP)
Assignee: Denka Seiken Co., Ltd.
G01N33/92C12Q1/60G01N2333/916
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,031,145
App. No.
14/001,766
Granted
Jul 24, 2018
Kind
B2
Abstract

Disclosed is a method for quantifying HDL2 cholesterol in a test sample without requiring laborious operations. The method for quantifying cholesterol comprises allowing phospholipase to act on HDL to quantify cholesterol. Also disclosed is a method comprising: a first step of transferring cholesterols other than high-density lipoproteins in a test sample to the outside of the reaction system; and a second step of quantifying high-density lipoprotein 2 cholesterol among the high-density lipoproteins remaining in the reaction system; wherein, by performing the second step by the above method, high-density lipoprotein 2 cholesterol in the test sample can be quantified.

Claims (11)

1. A method for quantifying cholesterol in high-density lipoprotein 2, said method comprising

reacting 0.1 to 200 U/mL phospholipase with high-density lipoprotein 2 and high-density lipoprotein 3 within a test sample,

wherein the phospholipase is phospholipase C and/or phospholipase D, and

quantifying the cholesterol in the high-density lipoprotein 2 within the test sample by measuring cholesterol from the reaction of the phospholipase with the high-density lipoprotein 2 and the high-density lipoprotein 3 within the test sample.

2. The method of claim 1 , wherein the test sample was not subjected to ultracentrifugation.

3. The method of claim 1 , wherein the method is performed in an automatic analyzer.

4. The method of claim 1 , wherein the test sample comprises high-density lipoprotein 2 and high-density lipoprotein 3 from a patient sample.

5. The method of claim 4 , wherein the patient sample is serum.

6. The method of claim 4 , wherein the patient sample is blood plasma.

7. The method of claim 1 , further comprising removal of cholesterols other than high density lipoproteins in the test sample to the outside of the reaction system prior to the reacting step of claim 1 .

8. The method of claim 1 , further comprising quantifying the cholesterol in the high-density lipoprotein 3 within the test sample.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2013
From: HIGUCHI, MAIKO; ITOH, YASUKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 031564/0145 →
Priority Claims (1)
JP 2011-042374 · Feb 28, 2011 · national
Continuity (1)
Related Publication 20140045201A1 · Feb 13, 2014